Status:
ACTIVE_NOT_RECRUITING
DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Crohn Disease
Bowel Cleansing
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Since 2009, many studies tend to prove the effectiveness of diffusion-weighted MR-enterography in the assessment of inflammatory activity in IBD compared to standard MR-enterography, with the emergenc...
Eligibility Criteria
Inclusion
- Any patient diagnosed with Crohn's disease with bowel involvement for whom a MR-enterography was ordered as part of their follow-up
- Age ≥ 18
- Subject's ability to understand and express opposition
- Affiliation to French social security system
Exclusion
- Any contraindication to MRI
- Allergy to gadolinium chelates
- Claustrophobia
- Major obesity that does not allow the patient to enter the machine's tunnel (whose diameter is 70 cm)
- Pregnant woman
- Person under curators or guardianship
Key Trial Info
Start Date :
April 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05354609
Start Date
April 26 2022
End Date
December 1 2025
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80054